Brookfield Asset Management Inc. Lantheus Holdings, Inc. Transaction History

Brookfield Asset Management Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Sep 25, 2023	BUY	$82.41 - $99.65 $1.76 Million - $2.13 Million	21,345 Added 69.35%	52,123 $4.37 Million
Q2 2023 Aug 14, 2023	BUY	$82.41 - $99.65 $1.76 Million - $2.13 Million	21,345 Added 69.35%	52,123 $4.37 Million
Q1 2023 Sep 25, 2023	SELL	$47.76 - $82.86 $1.02 Million - $1.77 Million	-21,345 Reduced 40.95%	30,778 $2.54 Million
Q1 2023 May 15, 2023	BUY	$47.76 - $82.86 $475,020 - $824,125	9,946 Added 47.74%	30,778 $2.54 Million
Q4 2022 Feb 14, 2023	BUY	$48.76 - $77.67 $1.02 Million - $1.62 Million	20,832 New	20,832 $1.06 Million
Q2 2022 Nov 16, 2022	BUY	$55.54 - $72.65 $1.05 Million - $1.37 Million	18,857 New	18,857 $1.25 Million
Q2 2022 Aug 15, 2022	BUY	$55.54 - $72.65 $119,966 - $156,924	2,160 Added 12.94%	18,857 $1.25 Million
Q1 2022 May 16, 2022	BUY	$24.28 - $56.64 $405,403 - $945,718	16,697 New	16,697 $923,000

534

68.9M

679K

414K

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $6.16B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

Get notified when there are updates to the investment portfolio of Brookfield Asset Management Inc., based on Form 13F filings with the SEC.

Stay updated on Brookfield Asset Management Inc. with notifications on news.